We're Open
+44 7340 9595 39
+44 20 3239 6980

Financing of Health Care

Information



  • Post Date 2018-11-08T11:09:44+00:00
  • Post Category New Samples

No Plagiarism Guarantee - 100% Custom Written

Order Details

Financing of Health Care

Financing of Health Care

INSTRUCTIONS:

Stein, R. (2010, November 8). Review of prostate cancer drugs Provenge renews medical cost-benefit debate. The Washington Post. Retrieved from http://www.washingtonpost.com/wp-dyn/content/article/2010/11/07/AR2010110705205.html This article describes a federal review conducted to determine whether Medicare expenditures should be allocated to an expensive prostate cancer vaccine. The author details both sides of the debate on the issue. Read the following case study, “Hard Economic and Finance Choices in US Healthcare” (Milstead): Case Study 1: Hard Economic and Finance Choices in US Healthcare Applied economics is all about managing scarce resources. Economics is an amoral field of study: it is neither moral nor immoral. Morality and values are determined by individuals at the personal level and by group consensus or majority opinion at the national level. State and federal governments determine the ‘will of the people’ about how to use scarce resources for the good of a nation. The U.S. health care system is an exemplar of scarcity: primary care physicians, substance abuse treatment centers, trauma centers, registered nurses, and the money to pay for goods and services. Finance is all about how to pay for goods and services. The Medicare Payment Advisory Commission (MedPAC) is appointed by the Executive branch of the federal government to make decisions about what the Medicare program will and will not pay for. In this role, MedPAC makes decisions about medications, procedures and treatments. Examples of MedPAC decisions include coverage for left ventricular assistive devices as a destination therapy, coverage for bariatric surgery, and in 2010, coverage of the drug Provenge™. By law, MedPAC is not allowed to use price or cost of any treatment in its decision-making processes. Review the information in the Washington Post article “Review of Prostate Cancer Drugs Provenge Renews Medical Cost-Benefit Debate” in the Learning Resources. Consider how policy decisions currently are made about what will and will not be paid for and what changes, if any, could improve the process. Reflect on how the Washington Post example illustrates the tension between cost and care. Post your analysis and assessment of the ethical and economic challenges related to policy decisions such as those presented in the Washington Post article. How does this type of situation contribute to the tension between cost and care? Substantiate your response with at least two outside resources.

CONTENT:
NameInstitutional affiliationCourseDateOver the years, many governments have been faced with the problems of financing healthcare. Most of the government officials have been engaged on cost-benefit debates on financing some of the killer diseases like cancer. Paolucci (2011) argues that many governments are reluctant to make a policy decision to fund major health care projects that need massive allocation of funds like the prostate cancer project in the United States. Although governments are not supposed to consider the cost factors in making healthcare policies, sometimes healthcare officials have enga...

Price: £ 99

100% Plagiarism Free & Custom Written, Tailored to your instructions